Formulary Monographs [METOCLOPRAMIDE, 5632]
|
|
METOCLOPRAMIDE
|
|
|
|
|
|
GI PROKINETIC AGENTS
|
|
|
Facilitation of small bowel intubation in X -ray procedures.
Esophageal reflux. Vomiting associated with cytotoxic agents. |
|
|
Restlessness, drowsiness, dizziness, fatigue, insomnia, headache. Exercise caution in activities requiring mental alertness. c.f. prescribing in renal disease p. 32. Avoid use with alcohol, tranquilisers and narcotics as added sedation occurs. Take 10-15 minutes before each meal.
|
|
|
Adult: Tabs:5-10mg 3 times daily . Pediatric: Oral 0.3-0.75mg/kg p er day in 3-4 divided doses. Intravenous: 2.5-10mg as a single dose (0.1mg/kg as a single dose in children under 6 y ears).
|
|
|
|
|
|
|
|
|
|
|
|
|